Ruberman, W., E. Weinblatt, J. D. Goldberg, C. W. Frank, and S. Shapiro. 1977. Ventricular premature beats and mortality after myocardial infarction. New England Journal of Medicine 297(14):750–757.

Schneeman, B. 2007. FDA’s review of scientific evidence for health claims. Journal of Nutrition 137(2):493–494.

Seshadri, S., A. L. Fitzpatrick, M. A. Ikram, A. L. DeStefano, V. Gudnason, M. Boada, J. C. Bis, A. V. Smith, M. M. Carassquillo, J. C. Lambert, D. Harold, E. M. Schrijvers, R. Ramirez-Lorca, S. Debette, W. T. Longstreth, Jr., A. C. Janssens, V. S. Pankratz, J. F. Dartigues, P. Hollingworth, T. Aspelund, I. Hernandez, A. Beiser, L. H. Kuller, P. J. Koudstaal, D. W. Dickson, C. Tzourio, R. Abraham, C. Antunez, Y. Du, J. I. Rotter, Y. S. Aulchenko, T. B. Harris, R. C. Petersen, C. Berr, M. J. Owen, J. Lopez-Arrieta, B. N. Varadarajan, J. T. Becker, F. Rivadeneira, M. A. Nalls, N. R. Graff-Radford, D. Campion, S. Auerbach, K. Rice, A. Hofman, P. V. Jonsson, H. Schmidt, M. Lathrop, T. H. Mosley, R. Au, B. M. Psaty, A. G. Uitterlinden, L. A. Farrer, T. Lumley, A. Ruiz, J. Williams, P. Amouyel, S. G. Younkin, P. A. Wolf, L. J. Launer, O. L. Lopez, C. M. van Duijn, and M. M. Breteler. 2010. Genome-wide analysis of genetic loci associated with Alzheimer disease. Journal of the American Medical Association 303(18):1832–1840.

Staessen, J. A., J. G. Wang, and L. Thijs. 2003. Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003. Journal of Hypertension 21(6):1055–1076.

Torpy, J. M., C. Lynm, and R. M. Glass. 2007. JAMA patient page. Implantable cardioverter-defibrillators. Journal of the American Medical Association 297(17):1946.

Trumbo, P., and K. Ellwood. 2009. Developing a framework for biomarker qualification for chronic disease. Paper presented at Committee on qualification of biomarkers and surrogate endpoints in chronic disease, Washington, DC.

Varmus, H. 2010. Ten years on—The human genome and medicine. New England Journal of Medicine 362(21):2028–2029.

Wagner, J. A. 2002. Overview of biomarkers and surrogate endpoints in drug development. Disease Markers 18(2):41–46.

Wang, T. J., P. Gona, M. G. Larson, G. H. Tofler, D. Levy, C. Newton-Cheh, P. F. Jacques, N. Rifai, J. Selhub, S. J. Robins, E. J. Benjamin, R. B. D’Agostino, and R. S. Vasan. 2006. Multiple biomarkers for the prediction of first major cardiovascular events and death. New England Journal of Medicine 355(25):2631–2639.

Yetley, E. A., C. M. Pfeiffer, R. L. Schleicher, K. W. Phinney, D. A. Lacher, S. Christakos, J. H. Eckfeldt, J. C. Fleet, G. Howard, A. N. Hoofnagle, S. L. Hui, G. L. Lensmeyer, J. Massaro, M. Peacock, B. Rosner, D. Wiebe, R. L. Bailey, P. M. Coates, A. C. Looker, C. Sempos, C. L. Johnson, and M. F. Picciano. 2010. NHANES monitoring of serum 25-hydroxy-vitamin D: A roundtable summary. Journal of Nutrition 140(11):2030S–2045S.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement